Emtricitabine and Tenofovir Disoproxil Fumarate

200mg/300mg

Product Details

Product Name:
Emtricitabine and Tenofovir Disoproxil Fumarate
Strength:
200mg/300mg
Count:
30
NDC:
42291-439-30
Class:
Brand Name(s):
Truvada
Imprint Code:
AC24
Color(s):
WHITE (white to off-white)
Shape:
CAPSULE
Score:
no score
Case Count:
Inactive Ingredients:
calcium stearate, croscarmellose sodium, hypromellose, microcrystalline cellulose, pregelatinized starch, titanium dioxide and triacetin
Indications and Usage:

1.1 Treatment of HIV-1 Infection
Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg.

1.2 HIV-1 Pre-Exposure Prophylaxis (PrEP)
Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test immediately prior to initiating emtricitabine and tenofovir disoproxil fumarate tablets for HIV-1 PrEP.

Pill Image

Label

Files